Advanced Medical Isotopes Corporation Signs Exclusive Global License for Advanced Resorbable Yttrium-90 Brachytherapy Seeds

Published: Oct 07, 2010

KENNEWICK, Wash., Oct. 7, 2010 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation, ("AMIC") (OTCQB:ADMD), a company engaged in the production and distribution of medical isotopes, is delighted to announce the execution of an exclusive world-wide license for patented technology for a proprietary brachytherapy seed with a fast-dissolving matrix for optimized delivery of radionuclides to cancer tissue.

Back to news